glp-1 and thc IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target Mounjaro and Smoking Weed: UK

Preliminary studies have found that GLP1 elicits a betacell preserving effect, and these sustained proliferative actions may cause unintentional exocrine and endocrine effects (e.g., pancreatitis, pancreatic cancer) [13]

Symptoms of GERD include: Heartburn Trouble sleeping Trouble swallowing Regurgitation (when food or liquid comes back up your throat) Chest pain Respiratory issues like asthma or cough Hyperhidrosis Some people have a condition where they experience excessive sweating regularly, not just at night

GLP-1 medications delay gastric emptying, meaning food sits in your stomach longer

That means there are multiple targets. One of the reasons that GLP-1s present such a potentially promising solution is that they specifically address cravings